These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The rationale for the use of low molecular weight heparin for hemodialysis treatments. Davenport A Hemodial Int; 2013 Oct; 17 Suppl 1():S28-32. PubMed ID: 24134328 [TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism. Ornstein DL; Hong-Dice YG; Papini JR Mil Med; 2001 Jul; 166(7):593-601. PubMed ID: 11469031 [TBL] [Abstract][Full Text] [Related]
5. Heparins, low-molecular-weight heparins, and pentasaccharides. Dinwoodey DL; Ansell JE Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464 [TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin in the treatment of deep venous thrombosis. Hauer KE West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594 [TBL] [Abstract][Full Text] [Related]
7. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients]. Kes P; Basić-Jukić N; Jurić I Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633 [No Abstract] [Full Text] [Related]
8. Heparin-induced thrombocytopenia and the clinical use of low molecular weight heparins in acute coronary syndromes. Cohen M Semin Hematol; 1999 Jan; 36(1 Suppl 1):33-6. PubMed ID: 9930562 [TBL] [Abstract][Full Text] [Related]
9. Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient. Dinwoodey DL; Ansell JE Cardiol Clin; 2008 May; 26(2):145-55, v. PubMed ID: 18406991 [TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin for the treatment of deep vein thrombosis. Thompson-Ford JK Pharmacotherapy; 1998; 18(4):748-58. PubMed ID: 9692649 [TBL] [Abstract][Full Text] [Related]
11. Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature. Brown P; Jay R; Fox A; Oliver M Hemodial Int; 2013 Jul; 17(3):444-9. PubMed ID: 23216938 [TBL] [Abstract][Full Text] [Related]
12. The use of unfractionated heparin and low molecular weight heparins in pregnancy. Casele HL Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684 [TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin in children. Albisetti M; Andrew M Eur J Pediatr; 2002 Feb; 161(2):71-7. PubMed ID: 11954754 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient. Nowak G; Bucha E; Brauns I; Czerwinski R Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807 [TBL] [Abstract][Full Text] [Related]
16. Heparin monitoring: clinical outcome and practical approach. Despas N; Larock AS; Jacqmin H; Douxfils J; Chatelain B; Chatelain M; Mullier F Ann Biol Clin (Paris); 2016 Dec; 74(6):637-652. PubMed ID: 27848915 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin. Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427 [TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients. Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336 [TBL] [Abstract][Full Text] [Related]